Literature DB >> 22974885

Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles.

G Sganga1, T Spanu, G Bianco, B Fiori, E Nure, G Pepe, T D'inzeo, M C Lirosi, F Frongillo, S Agnes.   

Abstract

Liver transplantation (OLT) is a lifesaving procedure for the treatment of many end-stage liver diseases, but infection and acute rejection episodes still remain the main causes of morbidity and mortality. Bloodstream infections (BSIs), particularly, are the major cause of mortality among these patients. BSIs in OLT, are from intra-abdominal, biliary, respiratory, urinary, wound and/or central venous catheter sources. A certain percentage are of unknown origin. Using the computerized database of our microbiology laboratory, we analyzed all BSIs in 75 consecutive adult liver transplant patients in a single center between January 2008 and July 2011. BSIs occurred in 21/75 (28%) patients. Thirteen subjects had a single; two, two episodes, and the other six patients each >4 episodes. All episodes occurred in the first 60 days following OLT; the majority (74%), in the first month. Among 44 microorganisms recovered, 52.3% were gram-negative, the most frequent being Pseudomonas aeruginosa and Klebsiella pneumoniae; 47.7% were gram-positive, the most frequent being coagulase-negative staphylococci, particularly Staphylococcus epidermidis. Overall 65.9% of the isolates were resistant to several antibiotics: 40.9% displayed the multiding-resistant and 25% the panding-resistant phenotype. There was a high incidence of gram-negative and most importantly, resistant bacteria, which required appropriate therapy. These data showed that it is imperative to promote strategies to prevention and contain antimicrobial resistance.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22974885     DOI: 10.1016/j.transproceed.2012.06.055

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  16 in total

Review 1.  Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias.

Authors:  Q Q Wan; Q F Ye; H Yuan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-12       Impact factor: 3.267

2.  Adjuvant Antibiotic Activity of Acidic Sophorolipids with Potential for Facilitating Wound Healing.

Authors:  Helen L Lydon; Niki Baccile; Breedge Callaghan; Roger Marchant; Christopher A Mitchell; Ibrahim M Banat
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses.

Authors:  Angela Chiereghin; Evangelia Petrisli; Matteo Ravaioli; Maria Cristina Morelli; Gabriele Turello; Diego Squarzoni; Giulia Piccirilli; Simone Ambretti; Liliana Gabrielli; Antonio Daniele Pinna; Maria Paola Landini; Tiziana Lazzarotto
Journal:  Med Microbiol Immunol       Date:  2016-10-25       Impact factor: 3.402

4.  Infections developing in patients undergoing liver transplantation: Recipients of living donors may be more prone to bacterial/fungal infections.

Authors:  Tansu Yamazhan; Cansu Bulut Avşar; Murat Zeytunlu; Meltem Taşbakan; Rüçhan Sertöz; Ayşın Zeytinoğlu; Şöhret Aydemir; Ömer Ünalp; Orkan Ergün; Alper Uğuz; Funda Özgenç; Fulya Günşar; İlker Turan; Sezgin Ulukaya; Nuri Deniz; Funda Yilmaz; Deniz Nart; Ezgi Güler; Kutsal Turhan; Zeki Karasu
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

Review 5.  Bacterial infection after liver transplantation.

Authors:  Sang Il Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

6.  Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection.

Authors:  Fei Gao; Qifa Ye; Qiquan Wan; Shan Liu; Jiandang Zhou
Journal:  Ther Clin Risk Manag       Date:  2015-03-26       Impact factor: 2.423

7.  Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation.

Authors:  Kuo-Hua Lin; Jien-Wei Liu; Chao-Long Chen; Shih-Hor Wang; Chih-Che Lin; Yueh-Wei Liu; Chee-Chien Yong; Ting-Lung Lin; Wei-Feng Li; Tsung-Hui Hu; Chih-Chi Wang
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

8.  A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patients.

Authors:  Fuat Hakan Saner; Knut Nowak; Dieter Hoyer; Peter Rath; Ali Canbay; Andreas Paul; Michael Koldehoff; Ahmet Elmaağaclı
Journal:  BMC Gastroenterol       Date:  2014-01-06       Impact factor: 3.067

9.  Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.

Authors:  Bingbing Qiao; Jianzhen Wu; Qiquan Wan; Sheng Zhang; Qifa Ye
Journal:  BMC Infect Dis       Date:  2017-02-27       Impact factor: 3.090

10.  The Distribution and Resistance of Pathogens Among Solid Organ Transplant Recipients with Pseudomonas aeruginosa Infections.

Authors:  Aijing Luo; Zhuqing Zhong; Qiquan Wan; Qifa Ye
Journal:  Med Sci Monit       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.